Cargando…
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines
INTRODUCTION: Uveal melanoma (UM) is the most common primary intraocular malignancy with very poor prognosis. Conventional chemotherapy only rarely prolongs the survival, therefore patients require novel treatment modalities. The discovery of specific receptors for hypothalamic hormones on cancer ce...
Autores principales: | Sipos, Eva, Dobos, Nikoletta, Rozsa, David, Fodor, Klara, Olah, Gabor, Szabo, Zsuzsanna, Szekvolgyi, Lorant, Schally, Andrew V, Halmos, Gabor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826244/ https://www.ncbi.nlm.nih.gov/pubmed/29503568 http://dx.doi.org/10.2147/OTT.S148174 |
Ejemplares similares
-
The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma
por: Fodor, Klara, et al.
Publicado: (2020) -
Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma
por: Treszl, Andrea, et al.
Publicado: (2013) -
Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer
por: Szabó, Zsuzsanna, et al.
Publicado: (2021) -
Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma
por: Sipos, Eva, et al.
Publicado: (2017) -
Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma
por: Fodor, Klára, et al.
Publicado: (2020)